Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Home Healthcare Market, by Type
1.4.2 North America Home Healthcare Market, by Indication
1.4.3 North America Home Healthcare Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Home Healthcare Market
Chapter 4. North America Home Healthcare Market by Type
4.1 North America Services Market by Country
4.2 North America Home Healthcare Market by Services Type
4.2.1 North America Skilled Nursing Market by Country
4.2.2 North America Rehabilitation Therapy Market by Country
4.2.3 North America Hospice & Palliative Care Market by Country
4.2.4 North America Unskilled Care Market by Country
4.2.5 North America Respiratory Therapy Market by Country
4.2.6 North America Infusion Therapy Market by Country
4.2.7 North America Pregnancy Care Market by Country
4.3 North America Product Market by Country
4.4 North America Home Healthcare Market by Product Type
4.4.1 North America Therapeutic Products Market by Country
4.4.2 North America Testing, Screening, & Monitoring Products Market by Country
4.4.3 North America Mobility Care Products Market by Country
Chapter 5. North America Home Healthcare Market by Indication
5.1 North America Cancer & Other Indications Market by Country
5.2 North America Respiratory Diseases Market by Country
5.3 North America Wound Care Market by Country
5.4 North America Pregnancy Market by Country
5.5 North America Movement Disorders Market by Country
5.6 North America Hearing Disorders Market by Country
5.7 North America Cardiovascular Diseases & Hypertension Market by Country
5.8 North America Diabetes Market by Country
Chapter 6. North America Home Healthcare Market by Country
6.1 US Home Healthcare Market
6.1.1 US Home Healthcare Market by Type
6.1.1.1 US Home Healthcare Market by Services Type
6.1.1.2 US Home Healthcare Market by Product Type
6.1.2 US Home Healthcare Market by Indication
6.2 Canada Home Healthcare Market
6.2.1 Canada Home Healthcare Market by Type
6.2.1.1 Canada Home Healthcare Market by Services Type
6.2.1.2 Canada Home Healthcare Market by Product Type
6.2.2 Canada Home Healthcare Market by Indication
6.3 Mexico Home Healthcare Market
6.3.1 Mexico Home Healthcare Market by Type
6.3.1.1 Mexico Home Healthcare Market by Services Type
6.3.1.2 Mexico Home Healthcare Market by Product Type
6.3.2 Mexico Home Healthcare Market by Indication
6.4 Rest of North America Home Healthcare Market
6.4.1 Rest of North America Home Healthcare Market by Type
6.4.1.1 Rest of North America Home Healthcare Market by Services Type
6.4.1.2 Rest of North America Home Healthcare Market by Product Type
6.4.2 Rest of North America Home Healthcare Market by Indication
Chapter 7. Company Profiles
7.1 Amedisys, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Acquisition and Mergers:
7.2 LHC Group, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Recent strategies and developments:
7.2.4.1 Partnerships, Collaborations, and Agreements:
7.2.4.2 Acquisition and Mergers:
7.3 ResMed, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.4 Omron Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Invacare Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Linde PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 A&D HOLON Holdings Company, Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.9 Fresenius SE & Co. KGaA
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. F. Hoffmann-La Roche Ltd.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Unique Offerings 